The National Institutes of Health has awarded a Small Business
Innovation Research (SBIR) grant to Ventria
Bioscience and the University of Southern California (USC), with the
... read more
A study comparing the in vivo receptor-binding and iron transport
characteristics of Ventria Bioscience’s Optiferrin™
recombinant human transferrin (rhTF) to native, serum-derived human
... read more
Ventria Bioscience announces the completion of an agreement under which
Ventria Bioscience will wholly acquire portions of the intellectual
property portfolio relating to Recombinant Lactoferrin developed by the ... read more